BusinessIchnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-ClassNewsmantraJuly 11, 2025 by NewsmantraJuly 11, 20250 CD38×BCMA×CD3 Trispecific Antibody · ISB 2001 is currently in Phase 1 clinical trial in patients with...
